Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  922 results for ""ECULIZUMAB""

Your Filters

Subject : atypical hemolytic uremic syndrome
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Eculizumab for pregnancy-related atypical hemolytic uremic syndrome.

  • Authors : Korotchaeva Y; Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.; Nephrology Center for Pregnant Women with Kidney Disease, Eramishantsev City Clinical Hospital, Moscow, Russia.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy ; Pregnancy Complications*/Pregnancy Complications*/Pregnancy Complications*/drug therapy

  • Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2024 Sep 27; Vol. Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Adult ; Humans

  • Source: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jan-Feb; Vol. 48 (1), pp. 16-22. Date of Electronic Publisher: Elsevier España Country of Publication: Spain NLM ID: 9440679 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.

  • Authors : Pala C; Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.; Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Parma, Italy.

Subjects: Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/drug therapy ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/diagnosis

  • Source: Journal of nephrology [J Nephrol] 2024 May; Vol. 37 (4), pp. 1141-1145. Date of Electronic Publication: 2023 Oct 17.Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059

Record details

Read More Add to Saved list
×
Academic Journal

Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.

  • Authors : Le Tilly O; Inserm U1327 ISCHEMIA 'Membrane signalling and inflammation in reperfusion injuries', Université de Tours, Tours, France.; Medical Pharmacology, CHRU Tours, Tours, France.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacokinetics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Models, Biological*

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 May; Vol. 90 (5), pp. 1312-1321. Date of Electronic Publication: 2024 Feb 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data.

  • Authors : Schönfelder K; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Kühne L

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy ; Drug Substitution*

  • Source: BMC nephrology [BMC Nephrol] 2024 Jun 19; Vol. 25 (1), pp. 202. Date of Electronic Publication: 2024 Jun 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

Read More Add to Saved list
×
Editorial & Opinion

Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS).

  • Authors : Santangelo L; Unit of Pediatric Nephrology, University Hospital 'Policlinico Consorziale - Giovanni XXIII', Bari, Italy.; Netti GS

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Humans ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/therapeutic use

  • Source: Indian journal of pediatrics [Indian J Pediatr] 2024 Feb; Vol. 91 (2), pp. 205. Date of Electronic Publication: 2023 Sep 30.Publisher: Dr. K. C. Chaudhuri Foundation, co-published by Springer India Country of Publication: India NLM ID: 0417442 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement.

  • Authors : Wildes DM; Department of Paediatric Nephrology and Transplantation, Children's Health Ireland, Dublin, Ireland. .; Harvey S

Subjects: Shiga-Toxigenic Escherichia coli* ; Escherichia coli Infections*/Escherichia coli Infections*/Escherichia coli Infections*/complications ; Escherichia coli Infections*/Escherichia coli Infections*/Escherichia coli Infections*/drug therapy

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Jan; Vol. 39 (1), pp. 315-324. Date of Electronic Publication: 2023 Jul 25.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes.

  • Authors : Konopásek P; Department of Pediatric Nephrology, 2nd Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic. .; Pediatrická Klinika 2. LF UK and FN v Motole, V Úvalu 84, Prague 5, 15006, Czech Republic. .

Subjects: Hemolytic-Uremic Syndrome*/Hemolytic-Uremic Syndrome*/Hemolytic-Uremic Syndrome*/complications ; Hemolytic-Uremic Syndrome*/Hemolytic-Uremic Syndrome*/Hemolytic-Uremic Syndrome*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Dec; Vol. 38 (12), pp. 4209-4215. Date of Electronic Publication: 2023 Jun 12.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Rational use of eculizumab in secondary atypical hemolytic uremic syndrome.

  • Authors : Cordero L; Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Cavero T

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Humans ; Retrospective Studies

  • Source: Frontiers in immunology [Front Immunol] 2024 Jan 11; Vol. 14, pp. 1310469. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

[Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Adult ; Humans

  • Source: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jan-Feb; Vol. 48 (1), pp. T16-T22. Date of Electronic Publisher: Elsevier España Country of Publication: Spain NLM ID: 9440679 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  922 results for ""ECULIZUMAB""